Drawing for MEDISORB

USPTO serial 79410739

MEDISORB

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MCNAMARA, SHANA MARIE
Law office
TMO LAW OFFICE 125

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MEDISORB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Gauze for medical purposes; adhesive plasters; bunion pads; bandages for dressings; gauze for dressings; scapulars for surgical purposes; surgical bandages; hygienic bandages; sticking plasters for medical purposes; medical bandages; adhesive bandages for medical purposes; elastic bandages for medical purposes; dressings for medical purposes; surgical dressings; ointments for pharmaceutical purposes; medicated lotions and creams for the body, skin, face, and hands; skin care preparations for medical purposes; medicated creams; acne creams [pharmaceutical preparations]; gels, creams and solutions for dermatological use; medicated lotions for treating dermatological conditions; medicated ointments for treating dermatological conditions; medicated creams for treating dermatological conditions; pharmaceutical preparations for the prevention of stretch marks; pharmaceutical lipsalves.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 14, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 27, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 27, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 29, 2026MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 29, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 1, 2025RFNTREFUSAL PROCESSED BY IB—
Jul 17, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 17, 2025RFRRREFUSAL PROCESSED BY MPU—
May 28, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 27, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2025DOCKASSIGNED TO EXAMINER—
Nov 29, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 29, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 28, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance